FDA Inspection 1208819 — Pharmasept Medical Products 1995 Ltd.

Pharmasept Medical Products 1995 Ltd. — FEI 3003623887

The FDA completed an inspection of Pharmasept Medical Products 1995 Ltd. on June 22, 2023 in Caesarea. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 6 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 22, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Caesarea (Israel)

Citations

IDCFRDescription
312721 CFR 820.80(e)Documentation
313021 CFR 820.100(a)Lack of or inadequate procedures
319921 CFR 820.40(a)Document review, approval documentation
48621 CFR 820.50(a)Evaluation of suppliers, contractors, etc., requirements
54621 CFR 820.75(a)Lack of or inadequate process validation
63021 CFR 803.17Lack of Written MDR Procedures